A new oral weight-loss drug from Pfizer could be more effective than the popular Ozempic injection, based on clinical trial results.

Share:
More In Business
The Fed’s Rate Cuts Will Be ‘Surgical’
Lara Rhame, FS Investments chief U.S. economist, discusses the recent market highs, how the job market is in a ‘good place,’ and why rates staying higher for longer might not be a bad thing.
Load More